Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study

被引:43
作者
Liang, Yajun [1 ,2 ]
Vetrano, Davide Liborio [1 ,3 ]
Qiu, Chengxuan [1 ,4 ]
机构
[1] Stockholm Univ, Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden
[2] Karolinska Inst, Dept Publ Hlth Sci, Widerstromska Huset, S-17177 Stockholm, Sweden
[3] Univ Cattolica Sacro Cuore, Dept Geriatr, Rome, Italy
[4] Shandong Univ, Shandong Prov Hosp, Dept Neurol, Jinan, Shandong, Peoples R China
基金
瑞典研究理事会;
关键词
Cardiovascular disease; Elderly; Mortality; Population study; Total cholesterol; ESC/EAS GUIDELINES; ASSOCIATION; PEOPLE; OUTCOMES; ADULTS; MANAGEMENT; STATINS; DISEASE; FRAILTY;
D O I
10.1186/s12877-017-0685-z
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: Whether the suggested inverse association between total cholesterol and mortality in old age varies according to cause of death and use of cholesterol medications remains to be elucidated. The aim of this study was to assess the associations of total cholesterol with cardiovascular and non-cardiovascular mortality in old age, and to explore whether their associations vary by use of cholesterol-lowering medications. Methods: The study participants included 3090 older adults (age >= 60 years, 63.7% women) from a population-based cohort study, i.e., the Swedish National study on Aging and Care in Kungsholmen, Stockholm. At baseline (2001-2004), data on demographic factors, lifestyles, cardiovascular risk factors, use of medications, global cognitive function, mobility limitation, and apolipoprotein E genotype were collected through interviews, clinical examinations, laboratory tests as well as from the Swedish national patient register. Vital statistics data (e.g., date and causes of death) till December 31, 2011 for all participants were derived from Swedish cause of death register. Data were analyzed using Cox proportional hazards model for all-cause mortality and Fine-Gray competing risks regression model for cause-specific mortality controlling for multiple potential confounders. Results: During 23,196 person-years of follow-up (median per person, 7.5 years), 1059 (34.3%) participants died. Compared to normal total cholesterol (<5.18 mmol/l), borderline-high (5.18-6.21 mmol/l) and high (>= 6.22 mmol/l) total cholesterol were associated with a decreased risk of all-cause mortality, with the multiple-adjusted hazard ratio (95% confidence interval, CI) of 0.71 (0.61-0.83) and 0.68 (0.57-0.80), respectively (P for trend <0.001). The competing risk regression models revealed that the reduced all-cause mortality associated with high total cholesterol (>= 6.22 mmol/l)) was mainly due to the reduced risk of non-cardiovascular mortality (hazard ratio = 0.67, 95% CI = 0.51-0.88). These associations were statistically evident only among individuals without use of cholesterol-lowering medications. Conclusions: The inverse association between high total cholesterol and reduced all-cause mortality in older adults is primarily due to non-cardiovascular mortality, especially among those who are not treated with cholesterol-lowering medications.
引用
收藏
页数:7
相关论文
共 28 条
[1]   Frailty and Mortality Outcomes in Cognitively Normal Older People: Sex Differences in a Population-Based Study [J].
Bartley, Mairead M. ;
Geda, Yonas E. ;
Christianson, Teresa J. H. ;
Pankratz, V. Shane ;
Roberts, Rosebud O. ;
Petersen, Ronald C. .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 (01) :132-137
[2]   Low total cholesterol and increased risk of dying: Are low levels clinical warning signs in the elderly? Results from the Italian longitudinal study on aging [J].
Brescianini, S ;
Maggi, S ;
Farchi, G ;
Mariotti, S ;
Di Carlo, A ;
Baldereschi, M ;
Inzitari, D .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (07) :991-996
[3]   Prospective association between low and high total and low-density lipoprotein cholesterol and coronary heart disease in elderly men [J].
Curb, JD ;
Abbott, RD ;
Rodriguez, BL ;
Masaki, K ;
Popper, J ;
Chen, R ;
Petrovitch, H ;
Blanchette, P ;
Schatz, I ;
Yano, K .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (12) :1975-1980
[4]  
Goff DC, 2014, CIRCULATION, V129, pS49, DOI [10.1161/01.cir.0000437741.48606.98, 10.1016/j.jacc.2013.11.005]
[5]   Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report [J].
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, R ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Cleeman, JI ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ ;
Keller, SA ;
Jehle, AJ .
CIRCULATION, 2002, 106 (25) :3143-3421
[6]   Association of mobility limitations with incident disability among older adults: a population-based study [J].
Heiland, Emerald G. ;
Welmer, Anna-Karin ;
Wang, Rui ;
Santoni, Giola ;
Angleman, Sara ;
Fratiglioni, Laura ;
Qiu, Chengxuan .
AGE AND AGEING, 2016, 45 (06) :812-+
[7]   Association of Frailty and Cardiometabolic Risk Among Community-Dwelling Middle-Aged and Older People: Results from the I-Lan Longitudinal Aging Study [J].
Hwang, An-Chun ;
Liu, Li-Kuo ;
Lee, Wei-Ju ;
Chen, Liang-Yu ;
Peng, Li-Ning ;
Lin, Ming-Hsien ;
Chen, Liang-Kung .
REJUVENATION RESEARCH, 2015, 18 (06) :564-572
[8]   Cholesterol, Statins, and Longevity From Age 70 to 90 Years [J].
Jacobs, Jeremy M. ;
Cohen, Aaron ;
Ein-Mor, Eliana ;
Stessman, Jochanan .
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2013, 14 (12) :883-888
[9]  
Keller HH, 2004, J GERONTOL A-BIOL, V59, P68
[10]   Low Cholesterol, Statins and Outcomes in Patients with First-Ever Acute Ischemic Stroke [J].
Koton, Silvia ;
Molshatzki, Noa ;
Bornstein, Natan M. ;
Tanne, David .
CEREBROVASCULAR DISEASES, 2012, 34 (03) :213-220